HBO₂ in snake envenomation (atrox albinus rattlesnake): a case report in a human | Canada Hyperbarics Skip to main content
Case Report Undersea Hyperb Med 2016

HBO₂ in snake envenomation (atrox albinus rattlesnake): a case report in a human

Zanon V, Morri A, Lonati D, Paoli A, Camporesi E, Bosco G — Undersea Hyperb Med, 2016

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers describe a case where a patient with severe rattlesnake envenomation received standard antivenom treatment supplemented with hyperbaric oxygen therapy.

What They Found

A patient with Grade 3 out of 3 rattlesnake envenomation received six daily hyperbaric oxygen treatments at 2.4 atmospheres absolute for 75 minutes each. The therapy was well tolerated, and long-term follow-up suggested it was reasonably and effectively administered in the post-acute phase.

Canadian Relevance

This case report has no direct Canadian relevance as the specific type of snake envenomation described is not common in Canada.

Study Limitations

As a case report, this study's findings are limited to a single patient and cannot be generalized to a broader population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Wound Care
Source Pubmed
PubMed ID 28763178
Year Published 2016
Journal Undersea Hyperb Med
MeSH Terms Animals; Anti-Bacterial Agents; Antivenins; Combined Modality Therapy; Crotalus; Hand Injuries; Humans; Hyperbaric Oxygenation; Immunoglobulin Fab Fragments; Male; Middle Aged; Snake Bites

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology